Stock & Company Details
Acumen Pharmaceuticals Inc $ABOS
Price:
N/A
N/A
72M
$172M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.40
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ABOS technical indicators
Latest Acumen Pharmaceuticals Inc (ABOS) indicator readings as of 2026-10-29.
ABOS's 14-day RSI is 54.7, in neutral territory. At $2.29 it is trading 8.7% below its 200-day moving average of $2.51, and below its 50-day average of $2.47. Price sits near the upper Bollinger Band ($1.63 to $2.42). ADX reads 24.2, sitting between trending and range-bound.
Overview
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believe to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.
Finance Bot
Ask your questions
Start by typing a question below.
